Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Vargatef, nintedanib (BIBF 1120)
Also known as: BIBF1120
print preview
bookmark
share with colleague
General Information
Company
Boehringer Ingelheim GmbH
Description
Small molecule inhibitor of multiple pro-angiogenic kinases including VEGF, PDGFR and fibroblast growth factor (FGF) receptor
Molecular Target
Vascular endothelial growth factor (VEGF) receptor
;
Platelet derived growth factor receptor (PDGFR)
Mechanism of Action
Platelet derived growth factor receptor (PDGFR) kinase inhibitor; Vascular endothelial growth factor (VEGF) receptor inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy